In the next step, we aimed to validate our most striking observation, i.e., the synergistic and almost complete reduction of xenograft tumor formation upon combined ITGB4 KD and E-/P-selectin KO by means of additional ITGB4-expressing xenograft models. The gene discussed is SELP; the disease is neoplasm.